Under the terms of the loan amendment, Beedie has agreed to convert $6 million out of the $7 million drawn as part of the initial $12 million loan at a price of C$5.56 per Metalla share as part of the conversion rights under the initial loan facility. The remaining $1 million outstanding is subject to conversion under the amendment. Valeo Pharma Inc ( CSE:VPH ), a Canadian specialty pharmaceutical company, announced Wednesday it has completed and filed its application to list its Class A shares on the OTCQB market in New York. The company said its listing on the OTCQB remains subject to it fulfilling all of the listing requirements and any other regulatory requirements. Valeo Pharma will continue to maintain the listing of its shares on the Canadian Securities Exchange under the symbol VPH.